The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.
April 25th 2024
This analysis highlighted several trends in search volume regarding eczema, including correlations with weather and climate.
Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Trials Show Immunotherapies Effective Against Advanced Melanoma
Results from two clinical trials reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 highlighted the potential for immunotherapies nivolumab and pembrolizumab as treatment for advanced melanomas, according to Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, and study.
CDC: Skin Ulcer Parasite Infection Spreading
New strains of leishmania, a parasitic disease that starts with skin ulcers, are spreading. The CDC reports on an outbreak in a group of 24 scientists and warns US physicians to be alert for the infection in travelers returning from Latin America and South America. The destruction of the Amazon rain forest may be playing a role.
In many medical school programs students might only get a few weeks of training in dermatology which likely will not cover all the conditions they will see, particularly working in hospitals. From fellowships to online learning there is a concerted effort underway to change that trend.
Q&A With Lindy Fox, MD, From UCSF Medical Center: Dermatology In Hospitals a Growing Field
In hospitals across the country patients are being admitted with conditions that can only be treated by specially trained dermatologists while others are developing issues during hospitalization. How quickly and how well they are treated can make a significant difference in patient care.
Elderly Woman With an Itchy Scalp
May 8th 2015This 76-year-old woman presented to clinic with 8 weeks of severe scalp itching. She had previously been treated with emollient lotion, baby oil, a dandruff shampoo containing pyrithione zinc, and hydroxyzine. Her past medical history includes eczema, hypertension, hyperlipidemia, paroxysmal SVT, GERD, and depression. She is retired, volunteers at an elementary school, and does not drink alcohol, smoke tobacco, or use recreational drugs.
Chronic Itch: Gastrointestinal Peptides as Possible Contributors
May 5th 2015Chronic itch (itch last 6 weeks or longer) is a clinical challenge, and is associated with a number of dermatologic, systemic, neuropathic, and psychogenic causes. Transmission of the itch sensation is similar to that of pain, but distinct in several ways. Scientists have found itch-specific neuronal pathways that when activated, cause considerable discomfort for patients. Current available treatments, however, are still more trial-and-error than evidence-based.
Are Medicare Patients Waiting Too Long for Melanoma Removal?
April 27th 2015Most oncologists recommend removing melanomas within 4 to 6 weeks of diagnostic biopsy. Researchers have analyzed Medicare's database to determine how quickly the highest risk population (elderly people) have melanomas removed. Their findings indicate 20 percent wait more than 1.5 months to have the malignancy removed, and roughly 8 percent wait longer than 3 months.
Momentum for a Melanoma Marker Modality
April 22nd 2015Any clinician who biopsies multiple melanocytic lesions per day daydreams about a modality that will consistently and accurately distinguish the neoplasms that haunt us the most: the ones with no clear diagnosis. New diagnostic technology may soon make that dream a reality.
Guttate Psoriasis As a Prognostic Marker for Plaque Psoriasis
The first guttate psoriasis (GP) episode, which is often triggered by an acute infection such as streptococcal pharyngitis, often results in patients developing chronic plaque psoriasis, according to research presented at the 73rd American Academy of Dermatology Annual Meeting.
Young Man with a Rash on His Chest
April 8th 2015This 29-year-old man came in for a wellness evaluation but notes having had this rash for 8 years. Occasionally it itches, but otherwise is asymptomatic and he has had no treatment for it to date. He does not take any medications and has no significant past medical history.
Treatment of Plaque Psoriasis Taking Big Steps Forward Part 2
While several new treatment options for plaque psoriasis and psoriatic arthritis have launched in recent years, there is still much work to be done in the field to help patients through long stretches of care.